Changes in lipid metabolism in women with age-related macular degeneration

Clinical and Experimental Medicine

Volumn 4, Issue 4, 2005, Pages 183-187

  Nowak, M ^a   Swietochowska, E ^a   Marek, B ^a   Szapska, B ^a   Wielkoszynski, T ^a   Kos Kudla, B ^a   Karpe, J ^a   Kajdaniuk, D ^a   Sieminska, L ^a   Glogowska Szelag, J ^a   Nowak, K ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

AMD; Serum lipids; Serum lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SPECTROMETRY; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; APOLIPOPROTEINS B; APOPROTEIN(A); CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; LIPID METABOLISM; LIPOPROTEIN(A); MACULAR DEGENERATION; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES;

EID: 20244380799     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-004-0054-z     Document Type: Article

References (37)

1. Hyman L (1987) Epidemiology of eye diseases in the elderly. Eye 1:330-341
2. Klein R, Klein BEK, Jensen SC, Meuer SM (1997) The five-years incidence and progression of age-related maculopathy. Ophthalmology 104:7-21
3. The International ARM Epidemiological Study Group (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 39:367-374
4. Beatty S, Murray IJ, Henson DB, Carden D, Kob HH, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42:439-446
5. Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE (2001) Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci 42:235-240
6. Piguet B, Wells JA, Palmvang IB (1993) Age-related Bruch's membrane change: a clinical study of the relative role of heredity and environment. Br J Ophthalmol 77:400-403
7. Silvestri G, Johnston PB, Hughes AE (1994) Is genetic predisposition an important risk factor in age-related macular degeneration? Eye 8:564-568
8. Seddon JM, Ajani UA, Mitchell BD (1997) Familial aggregation of age-related maculopathy. Am J Ophthalmol 123:199-206
9. Kimura K, Isashiki Y, Sonoda S, Kakiuchi-Matsumoto T, Ohba N (2000) Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 130:769-773
10. Klein R, Klein BE, Linton KL, DeMets DL (1993) The Beaver Dam Eye Study: the relation of age related maculopathy to smoking. Am J Epidemiol 137:190-200
11. The Eye Disease Case-Control Study Group (1992) Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110:1701-1708
12. Cruickshanks KJ, Klein R, Klein BE (1993) Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol 111:514-518
13. Mares-Perlman JA, Klein R, Klein BEK, Greger JL, Brady WE, Palta M, Ritter L (1996) Association of zinc and antioxidant nutrient with age-related maculopathy. Arch Ophthalmol 114:991-997
14. Smith W, Mitchell P, Rochester C (1997) Serum beta carotene, alpha tocopherol, and age-related maculopathy: The Blue Mountains Eye Study. Am J Ophthalmol 104:838-840
15. Nowak M, Swietochowska E, Wielkoszynski T, Marek B, Karpe J, Gorski J, Glogowska-Szelag J, Kos-Kudla B, Ostrowska Z (2003) Changes in blood antioxidants and several lipid peroxidation products in women with age-related macular degeneration. Eur J Ophthalmol 13:281-286
16. Beaty S, Koh HH, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115-134
17. Hyman L, Schachat AP, He Z, Leske C (2000) Hypertension, cardiovascular disease, and age-related macular degeneration. Arch Ophthalmol 118:351-358
18. Ross RD, Barofsky JM, Cohen G, Baber WB, Palao SW, Gitter KA (1998) Presumed macular choroidal watershed vascular filling, choroidal neovascularization, and systemic vascular disease in patients with age-related macular degeneration. Am J Ophthalmol 125:71-80
19. Smith W, Mitchell P, Leeder SR, Wang JJ (1998) Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy. Arch Ophthalmol 116:583-587
20. Ikeda T, Obayashi H, Hasegawa G, Nakamura N, Yoshikawa T, Imamura Y, Koizumik Y, Kinoshita S (2001) Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factor for exudative age-related macular degeneration. Am J Ophthalmol 132:191-195
21. Klein R, Klein BEK, Jensen SC (1997) The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy. Ophthalmology 104:1804-1811
22. Nowak M, Swietochowska E, Szapska B, Marek B, Koziol H, Kajdaniuk D, Ostrowska Z, Sieminska L, Glogowska-Szelag J, Klimek J (2003) Chosen parameters of the lipid and homocysteine metabolism in exudative age-related macular degeneration. Eur J Clin Invest 33[Suppl 1]:12
23. Klein R, Klein BE, Franke T (1993) The relationship of cardiovascular disease and its risk factors to age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 100:406-414
24. Nowak M, Swietochowska E, Szapska B, Marek B, Koziol H, Kajdaniuk D, Kos-Kudla B, Ostrowska Z, Sieminska L, Glogowska-Szelag J, Karpe J (2003) The apolipoprotein E polymorphism in exudative age-related macular degeneration. Eur J Clin Invest 33[Suppl 1]:12
25. Klaver CCW, Kliffen M, van Duijn CM, Hofman A, Cruts M, Grobbee DE (1998) Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 63:200-206
26. Rosseneu MY, Labeur C (1990) Apolipoprotein structure, function and measurement. Curr Opin Lipidol 1:508-513
27. Kostner GM (1983) Apolipoproteins and lipoproteins of human plasma: significance in health and disease. Adv Lipid Res 20:1-41
28. Hirvela H, Luukinen H, Laara E, Laatikainen L (1996) Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 103:871-877
29. Klein R, Klein BEK, Linton KLP (1992) Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99:933-943
30. Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT (1995) Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 142:404-409
31. Hyman LG, Lilienfeld AM, Rerris FL, Fine SL (1983) Senile macular degeneration: a case-control study. Am J Epidemiol 118:213-227
32. Sperduto R, Hiller R (1986) Systemic hypertension and age-related maculopathy in the Framingham Study. Arch Ophthalmol 104:216-219
33. Vinding T, Appleyard M, Nyobe J, Jensen G (1992) Risk factor analysis for atrophic and exudative age-related macular degeneration: an epidemiological study of 1000 aged individuals. Acta Ophthalmol 70:66-72
34. Blumenkranz MS, Russell SR, Robey MG, Kott-Blumenkranz R, Penneys N (1986) Risk factors in age-related maculopathy complicated by choroidal neovascularisation. Ophthalmology 93:552-558
35. Tsang NC, Penfold PL, Snitch PJ, Billson F (1992) Serum level of antioxidants and age-related macular degeneration. Doc Ophthalmol 81:387-400
36. Belda Sanchis JI, Quijada Gonzalez A, Munoz Ruiz G, Rodriguez-Galietero A, Romero Gomez FJ, Diaz-Llopis M (2001) Are blood lipids a risk factor for age-related macular degeneration? Arch Soc Esp Oftalmol 76:13-17
37. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MOM (1988) Factors associated with AMD: analyses of data from the first NHANES. Am J Epidemiol 128:700-710